Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

Chromothripsis is detectable in 20–30% of newly diagnosed multiple myeloma (NDMM) patients and is emerging as a new independent adverse prognostic factor. In this study we interrogate 752 NDMM patients using whole genome sequencing (WGS) to investigate the relationship of copy number (CN) signatures...

Descripción completa

Detalles Bibliográficos
Autores principales: Maclachlan, Kylee H., Rustad, Even H., Derkach, Andriy, Zheng-Lin, Binbin, Yellapantula, Venkata, Diamond, Benjamin, Hultcrantz, Malin, Ziccheddu, Bachisio, Boyle, Eileen M., Blaney, Patrick, Bolli, Niccolò, Zhang, Yanming, Dogan, Ahmet, Lesokhin, Alexander M., Morgan, Gareth J., Landgren, Ola, Maura, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397708/
https://www.ncbi.nlm.nih.gov/pubmed/34453055
http://dx.doi.org/10.1038/s41467-021-25469-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397708/
https://www.ncbi.nlm.nih.gov/pubmed/34453055
http://dx.doi.org/10.1038/s41467-021-25469-8

Ejemplares similares